UK's Smiths Group will have to navigate national security concerns to secure a sale of its screening and detection business to a foreign buyer, but the engineering group believes the disposal is ...
AstraZeneca is no longer pursuing plans for a 450 million pound ($558.32 million) vaccine manufacturing plant in Speke, Liverpool, a company spokesperson said on Friday.